Wall Street looks up after positive Intel earnings
April 16, 2008 / NewJersey.comTechnology stocks were poised to lead Wall Street higher today after Intel issued a stronger-than-expected... Add comment
AstraZeneca today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder (GAD), including...
More Anxiety Medicines News >>
Technology stocks were poised to lead Wall Street higher today after Intel issued a stronger-than-expected... Add comment
In two weeks college students will participate in National Stress Out Day, a nationwide effort... Add comment
The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 23,... Add comment
© 2008 Anxiety Medicines. All rights reserved. Contact Anxiety Medicines. Advertise. Privacy Policy